<i>Holothuria Leucospilota</i> Polysaccharides Ameliorate Hyperlipidemia in High-Fat Diet-Induced Rats via Short-Chain Fatty Acids Production and Lipid Metabolism Regulation

• Main Authors: Yiqiong Yuan, Qibing Liu, Fuqiang Zhao, Jun Cao, Xuanri Shen, Chuan Li
• Format: Article
• Language: English
• Published: MDPI AG 2019-09-01
• Series: International Journal of Molecular Sciences
• Subjects: <i>Holothuria leucospilota</i>; polysaccharides; hyperlipidemia; high-fat diet; short-chain fatty acids; lipid metabolism; gut microbiota
• Online Access: https://www.mdpi.com/1422-0067/20/19/4738
• ISSN: 1422-0067

<i>Holothuria leucospilota</i> polysaccharides (HLP) are expected to become potential resources for the treatment of hyperlipidemia because of their various bioactivities. In the study, the treatment of HLP on improving hyperlipidemia in rats was explored. Oral administration of HLP at 100 or 200 mg/kg body weight effectively alleviated serum lipid levels and liver histological abnormalities in high-fat-diet rats. HLP regulated abnormal mRNA, lipogenesis-related hormones and inflammatory cytokines (tumor necrosis factor-&#945;, interleukin-6 and interleukin-12) levels. HLP improved the ability of gut microbiota to produce short-chain fatty acids (SCFAs). SCFAs have been found to ameliorate liver lesions. Therefore, HLP alleviated hyperlipidemia by improving the levels of SCFAs to regulate lipid metabolism. These results indicated that HLP could be used as beneficial polysaccharides to alleviate hyperlipidemia.